MIVACURIUM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Mivacurium Chloride patents expire, and when can generic versions of Mivacurium Chloride launch?
Mivacurium Chloride is a drug marketed by Rising and Woodward and is included in two NDAs.
The generic ingredient in MIVACURIUM CHLORIDE is mivacurium chloride. There are two drug master file entries for this compound. Additional details are available on the mivacurium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MIVACURIUM CHLORIDE?
- What are the global sales for MIVACURIUM CHLORIDE?
- What is Average Wholesale Price for MIVACURIUM CHLORIDE?
Summary for MIVACURIUM CHLORIDE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 2 |
Patent Applications: | 622 |
DailyMed Link: | MIVACURIUM CHLORIDE at DailyMed |
Recent Clinical Trials for MIVACURIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Jiangsu Nhwa Pharmaceutical Co., Ltd. | Phase 2 |
Tang-Du Hospital | Phase 2 |
Jiangsu Nhwa Pharmaceutical Co., Ltd. | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for MIVACURIUM CHLORIDE
US Patents and Regulatory Information for MIVACURIUM CHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | MIVACURIUM CHLORIDE | mivacurium chloride | INJECTABLE;INJECTION | 078562-001 | Apr 30, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Woodward | MIVACURIUM CHLORIDE | mivacurium chloride | SOLUTION;INTRAVENOUS | 209708-001 | Oct 12, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Woodward | MIVACURIUM CHLORIDE | mivacurium chloride | SOLUTION;INTRAVENOUS | 209708-002 | Oct 12, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |